Panagiotis Tsourapas - May 10, 2023 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)

Role
Grp Pres, Eur& Developing Mkts
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact
Stock symbol
CL
Transactions as of
May 10, 2023
Transactions value $
-$305,364
Form type
4
Date filed
5/12/2023, 04:10 PM
Previous filing
May 5, 2023
Next filing
Sep 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CL Common Stock Options Exercise $1M +13.7K +198.35% $73.00 20.6K May 10, 2023 Direct F1
transaction CL Common Stock Sale -$1.11M -13.7K -66.48% $81.08 6.91K May 10, 2023 Direct F2, F3
transaction CL Common Stock Sale -$195K -2.4K -74.52% $81.01 822 May 10, 2023 By Spouse F4
holding CL Common Stock 4.14K May 10, 2023 By Issuer's 401(k) Plan Trustee
holding CL Common Stock 59.3K May 10, 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CL Stock Option (Right to Buy) Options Exercise $0 -13.7K -100% $0.00* 0 May 10, 2023 Common Stock 13.7K $73.00 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of stock options awarded under the issuer's incentive compensation plan.
F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $81.07 to $81.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $81.00 to $81.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date.